Johnson & Johnson

Oppenheimer updates its top 50 buy list, rotating away from big banks

Seeking Alpha · 3 h ago

Pharma sector doubles down on AI to slash costs, timelines

Reuters · 5 h ago

Johnson & Johnson Announces New Data For Tremfya

Reuters · 6 h ago

Notable healthcare headlines for the week: J&J, UnitedHealth, and CVS in focus

Seeking Alpha · 29 h ago

Earnings Scoreboard: 83% of S&P 500 early reporters beat EPS estimates as Y/Y profit growth hits 23 firms

Seeking Alpha · 2 d ago

Dividend Roundup: Johnson & Johnson, Coca-Cola, Costco, CVS Health, and more

Seeking Alpha · 3 d ago

Lilly, Pfizer, J&J among winners of EU drug recommendations this month

Seeking Alpha · 3 d ago

Vini Cosmetics Ropes In Manoj Gadgil As CEO

Businessworld · 4 d ago

Johnson & Johnson Is Maintained at Overweight by Morgan Stanley

Dow Jones Newswires · 4 d ago

Health Rounds: Glucose monitoring devices for type 2 diabetes benefit even those not on insulin

Reuters · 4 d ago

Johnson & Johnson Price Target Cut to $272.00/Share From $276.00 by Leerink Partners

Dow Jones Newswires · 5 d ago

Johnson & Johnson Price Target Cut to $275.00/Share From $282.00 by Wells Fargo

Dow Jones Newswires · 5 d ago

Johnson & Johnson Is Maintained at Outperform by RBC Capital

Dow Jones Newswires · 5 d ago

RBC Capital maintains Outperform rating on Johnson & Johnson, $280 price target

TradingView · 5 d ago

SLS, IBRX Rise Premarket: Funds Raise Their Bets As J&J Stays ‘On The Lookout’ For Deals

Stocktwits · 5 d ago

Johnson & Johnson Stocks Fall 4.7% Despite Higher Full-Year Guidance

GuruFocus · 6 d ago

Stocks making big moves after hours: BAC, KNDI, C

Seeking Alpha · 6 d ago

Top News Today: Stocks Fall; Bank Earnings Mixed; Chips Hit by China Fears

Dow Jones Newswires · 6 d ago

Johnson & Johnson leaning toward spinning out hips-and-knees business - WSJ

Seeking Alpha · 6 d ago